NACDS Medicare Rx Message: Keep Plan Design Simple
Executive Summary
NACDS is concerned about the "confusion and conflict" likely to occur in retail pharmacies in implementing a Medicare prescription drug benefit as proposed in the bills pending in Congress
You may also be interested in...
Medicare PBM Restrictions Would Lead To Higher Premiums, CBO Says
The PBM "transparency" provision in the Senate's Medicare prescription drug bill would lead to higher monthly premiums and higher beneficiary cost-sharing, the Congressional Budget Office said
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA Skin Infections Guidance Spurs Debate On Endpoint Relevance
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials